ICAHN CARL C
Institutional investor · Portfolio as of Q4 2020
Top Holdings18 positions
ICAHN ENTERPRISES LP | 221.7M | $11.2B | 56.0% | $14.88 | +12.04% | 9 qtrssince 2018-Q4 | Increased 67 |
OCCIDENTAL PETE CORP | 88.6M | $1.5B | 7.6% | $18.97 | -11.00% | 7 qtrssince 2019-Q2 | Unchanged 0 |
CVR ENERGY INC | 71.2M | $1.1B | 5.3% | $19.52 | -51.47% | 9 qtrssince 2018-Q4 | Unchanged 0 |
HERBALIFE NUTRITION LTD | 20.5M | $985.3M | 4.9% | $58.20 | -17.89% | 9 qtrssince 2018-Q4 | Unchanged 0 |
CHENIERE ENERGY INC | 16.2M | $970.6M | 4.8% | $55.31 | +3.25% | 9 qtrssince 2018-Q4 | Decreased 0 |
NEWELL BRANDS INC | 43.7M | $927.8M | 4.6% | $13.04 | +29.82% | 9 qtrssince 2018-Q4 | Unchanged 0 |
NAVISTAR INTL CORP NEW | 16.7M | $735.4M | 3.7% | — | — | 9 qtrssince 2018-Q4 | Unchanged 0 |
CLOUDERA INC | 52.3M | $727.9M | 3.6% | — | — | 6 qtrssince 2019-Q3 | Unchanged 0 |
XEROX HOLDINGS CORP | 27.8M | $667.2M | 3.3% | $19.93 | -15.25% | 6 qtrssince 2019-Q3 | Increased 61 |
HERC HLDGS INC | 4.5M | $298.5M | 1.5% | $23.61 | +158.03% | 9 qtrssince 2018-Q4 | Unchanged 0 |
CONDUENT INC | 38.1M | $183.1M | 0.9% | $9.55 | -50.60% | 9 qtrssince 2018-Q4 | Unchanged 0 |
DELEK US HLDGS INC NEW | 10.5M | $169.4M | 0.8% | $13.28 | +4.59% | 4 qtrssince 2020-Q1 | Unchanged 0 |
WELBILT INC | 11.9M | $157.6M | 0.8% | — | — | 9 qtrssince 2018-Q4 | Unchanged 0 |
| 19.3M | $131.5M | 0.7% | — | — | — | Unchanged 0 | |
BAUSCH HEALTH COS INC | 5M | $104.7M | 0.5% | $20.06 | 0.00% | 1 qtr | New 61 |
DANA INC | 4M | $77.8M | 0.4% | $17.07 | 0.00% | 1 qtr | New 52 |
| 7.3M | $77.2M | 0.4% | $9.68 | -30.89% | 9 qtrssince 2018-Q4 | Decreased 0 | |
SANDRIDGE ENERGY INC | 4.8M | $14.9M | 0.1% | $5.53 | -59.49% | 9 qtrssince 2018-Q4 | Unchanged 0 |
ICAHN CARL C manages $20.1B across 18 positions as of Q4 2020. Top holdings: IEP (56.0%), OXY (7.6%), CVI (5.3%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Added 2 new positions, increased 2, trimmed 2. Top move: IEP (INCREASED, conviction 67). Portfolio: $20.1B across 18 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR